Curis Lifesciences Limited

07 Nov 2025 - 11 Nov 2025 Individual Category SME NSE

Min Investment

₹256000

Price Band

₹120-₹128

Issue Size

₹15.41 Lakh

Lot Size

1000 (per lot)

IPO Dates
img

07 Nov 2025

Open Date

img

11 Nov 2025

Close Date

img

TBI

Allotment Date

img

14 Nov 2025

Listing Date

Know Before Investing

Strengths icon

  • Experienced promoters with over 15 years in the pharmaceutical industry.
  • Wide product portfolio of 943 approved formulations across multiple therapeutic segments.
  • WHO-GMP certified manufacturing facility ensuring global quality standards.
  • Presence in both domestic and international markets through contract and license manufacturing.
  • Registrations with multiple international health authorities, including Kenya, Philippines, Yemen, and Nigeria

Weaknesses icon

  • Dependence on a limited number of customers for significant revenue share.\
  • Any regulatory non-compliance may impact manufacturing operations.
  • Exposure to litigation risks including trademark and compliance-related cases.
  • Volatility in raw material prices could affect profitability.
  • Adverse government or export policy changes may impact business performance.

About Curis Lifesciences Limited

Our business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic onloan license or contract Manufacturing and own brand marketing basis. Our business is majorly on principle to principlebasis with different marketers. As on the date of this Draft Red Herring Prospectus, we cater to more than 100 corporateclients on loan license and/or contract manufacturing basis along with 2 clients for own brand marketing globally ofRepublic of Yemen and Kenya. Our company has commenced manufacturing facility in year 2017, hence, our companyhas experience of more than 5 years in the current line of business of the company. as on the date of this Draft Red HerringProspectus our manufacturing facility at Curis Lifesciences Limited is installed with capacity to manufacture 138 Croretables / year, 15.75 Crore Capsules / year, 1080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45Tons sterile ophthalmic ointment / year. Our promoters have a vast experience in the pharmaceutical manufacturingIndustry. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, ourPromoters have been the pillars of our Company's growth and have built a strong value system for our Company. Withtheir enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical industry

IPO Objectives

1. i.Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities;ii.Capital Expenditure towards Construction of a Storage Facility;iii.Pre-payment/Repayment of outstanding Secured Loans;iv.Product Registrations in other countries;v.Funding our Working Capital Requirements; andvi.General Corporate Purpose.

Company Promoters

Dharmesh Dashrathbhai Patel

Jaimik Mansukhbhai Patel

Piyush Gordhanbhai Antala

Siddhant Jayantibhai Pawasia

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account